Matches in Nanopublications for { ?s ?p "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP181697.RAnpL7t3GWMeBBwQSRYi2pWc8lOke47PvUiqv2zy9qVds130_assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181697.RAnpL7t3GWMeBBwQSRYi2pWc8lOke47PvUiqv2zy9qVds130_provenance.
- assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP512726.RAfeUJ4crHhsLmFwLXOTElY03kuJhuijqaU7lzMygT9bA130_assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512726.RAfeUJ4crHhsLmFwLXOTElY03kuJhuijqaU7lzMygT9bA130_provenance.
- NP859945.RAoOYImOmC41sU3EvIAi4JHGRGwSCL-qDYK3tnXyp5pyg130_assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859945.RAoOYImOmC41sU3EvIAi4JHGRGwSCL-qDYK3tnXyp5pyg130_provenance.
- NP820616.RAJq7Fq7X3ePghewpi0L75iNiRoCLc643rba1e4qg46dQ130_assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820616.RAJq7Fq7X3ePghewpi0L75iNiRoCLc643rba1e4qg46dQ130_provenance.
- NP512730.RAiDP-SYvCDvVfXim0OPjX67kHQ_vIYXwJy8wZuWGmc7E130_assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512730.RAiDP-SYvCDvVfXim0OPjX67kHQ_vIYXwJy8wZuWGmc7E130_provenance.
- NP978325.RAHWXLJR2r3SKvtz-KGes9OPJDTsARrTYL7dCKjMwtzQM130_assertion description "[Results observed in FVB-PyMT mice, a robust transgenic model of highly metastatic breast carcinoma, fitted the expectation that relatively high expression levels of ADAMTS8 together with low expression levels of ADAMTS15 seen in human breast carcinoma are associated with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978325.RAHWXLJR2r3SKvtz-KGes9OPJDTsARrTYL7dCKjMwtzQM130_provenance.